Evidence-Based Indications for Treatment of Uterine Fibroids in Gynecology

Fibroids

Volumn , Issue , 2013, Pages 24-35

  Nodler, James L ^a   Segars, James H ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Evidence based; Fibroids; Gynecology; Indications; Treatment

Indexed keywords

EID: 84887238697     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118456996.ch3     Document Type: Chapter

References (33)

1. Bulletti C, Ziegler D, Levi Setti P, Cicinelli E, Polli V, Stefanetti M. Myomas, pregnancy outcome, and in vitro fertilization. Ann N Y Acad Sci 2004; 1034: 84-92.
2. Casini ML, Rossi F, Agostini R, Unfer V. Effects of the position of fibroids on fertility. Gynecol Endocrinol 2006; 22: 106-109.
3. Chwalisz K, Larsen L, Mattia-Goldberg C, Edmonds A, Elger N, Winkel CA. A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata. Fertil Steril 2007; 87: 1399-1412.
4. Cook H, Ezzati M, Segars JH, McCarthy K. The impact of uterine leiomyomas on reproductive outcomes. Minerva Ginecol 2010; 62: 225-236.
5. Esteve JL, Acosta R, Pérez Y, Campos R, Hernéndez AV, Texidó CS. Treatment of uterine myoma with 5 or 10 mg mifepristone during 6 months, posttreatment evolution over 12 months: double-blind randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 2012; 161(2): 202-208.
6. Ezzati M, Norian JM, Segars JH. Management of uterine fibroids in the patient pursuing assisted reproductive technologies. Women's Health (Lond Engl) 2009; 5: 413-421.
7. Ferrero S, Abbamonte LH, Giordano M, Parisi M, Ragni N, Remorgida V. Uterine myomas, dyspareunia, and sexual function. Fertil Steril 2006; 86: 1504-1510.
8. Grigorieva V, Chen-Mok M, Tarasova M, Mikhailov A. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 2003; 79: 1194-1198.
9. Hehenkamp WJ, Volkers NA, Birnie E, Reekers JA, Ankum WM. Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy-results from the randomized clinical Embolisation versus Hysterectomy (EMMY) Trial. Radiology 2008; 246: 823-832.
10. Kjerulff KH, Langenberg PW, Rhodes JC, Harvey LA, Guzinski GM, Stolley PD. Effectiveness of hysterectomy. Obstet Gynecol 2000; 95: 319-326.
11. La Marca A, Musacchio MC, Morgante G, Petraglia F, de Leo V. Hemodynamic effect of danazol therapy in women with uterine leiomyomata. Fertil Steril 2003; 79: 1240-1242.
12. Lasmar RB, Xinmei Z, Indman PD, Celeste RK, di Spiezio Sardo A. Feasibility of a new classification of submucous myomas: a multicenter study. Fertil Steril 2011; 95: 2773-2777.
13. Laughlin SK, Hartmann KE, Baird DD. Postpartum factors and natural fibroid regression. Am J Obstet Gynecol 2011; 204: 496.
14. Levens ED, Potlog-Nahari C, Armstrong AY, et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstet Gynecol 2008; 111: 1129-1136.
15. Lippman SA, Warner M, Samuels S, Olive D, Vercellini P, Eskenazi B. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril 2003; 80: 1488-1494.
16. Magalhães J, Aldrighi JM, de Lima GR. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception 2007; 75: 193-198.
17. Olive DL, Lindheim SR, Pritts EA. Non-surgical management of leiomyoma: impact on fertility. Curr Opin Obstet Gynecol 2004; 16: 239-243.
18. Ouyang DW, Economy KE, Norwitz ER. Obstetric complications of fibroids. Obstet Gynecol Clin North Am 2006; 33: 153-169.
19. Parker WH. Uterine myomas: management. Fertil Steril 2007; 88: 255-271.
20. Parsanezhad ME, Azmoon M, Alborzi S, et al. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril 2010; 93: 192-198.
21. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009; 91: 1215-1223.
22. Rackow BW, Taylor HS. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril 2010; 93: 2027-2034.
23. Roovers JP, van der Bom JG, van der Vaart CH, Heintz AP. Hysterectomy and sexual wellbeing: prospective observational study of vaginal hysterectomy, subtotal abdominal hysterectomy, and total abdominal hysterectomy. BMJ 2003; 327: 774-778.
24. Somigliana E, Vercellini P, Daguati R, Pasin R, de Giorgi O, Crosignani PG. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update 2007; 13: 465-476.
25. Spies JB, Bradley LD, Guido R, Maxwell GL, Levine BA, Coyne K. Outcomes from leiomyoma therapies: comparison with normal controls. Obstet Gynecol 2010; 116: 641-652.
26. Stewart EA. Uterine fibroids. Lancet 2001; 357: 293-298.
27. Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006; 85: 22-29.
28. Stovall DW. Clinical symptomatology of uterine leiomyomas. Clin Obstet Gynecol 2001; 44: 364-371.
29. Stovall DW. Alternatives to hysterectomy: focus on global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound. Menopause 2011; 18: 437-444.
30. Van der Kooij SM, Bipat S, Hehenkamp WJ, Ankum WM, Reekers JA. Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis. Am J Obstet Gynecol 2011; 205(4): 317.
31. Vercellini P, Zàina B, Yaylayan L, Pisacreta A, de Giorgi O, Crosignani PG. Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility. Obstet Gynecol 1999; 94: 341-347.
32. Volkers NA, Hehenkamp WI, Birnie E, Ankum WM, Reekers JA. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. Am J Obstet Gynecol 2007; 196: 519.
33. Voogt MJ, de Vries J, Fonteijn W, Lohle PNM, Boekkooi PF. Sexual functioning and psychological well-being after uterine artery embolization in women with symptomatic uterine fibroids. Fertil Steril 2009; 92: 756-761.